Author

Diana Paola Arteaga

Observed names: Arteaga Ceballos, Diana Paola, D.P. Arteaga, Diana P Arteaga, Diana P. Arteaga

Institutions: Health Sciences North, NOSM University

Observed institutions: Western University, University Health Network, University of Toronto, Universidad El Bosque, Princess Margaret Cancer Centre, Health Sciences North, Instituto Nacional de Cancerología, NOSM University

ORCID: 0000-0001-5980-8205

Observed ORCID: 0000-0001-5980-8205

OpenAlex ID: A5018898758

Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy

2021 · April A N Rose, Susan M Armstrong, et al. · Journal for ImmunoTherapy of Cancer · 51

Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patients

2024 · S. Genta, D.V. Araujo, et al. · ESMO Open · 30

Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al. · Cancer Research Communications · 16

CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus

2021 · Thiago P. Muniz, Daniel V. Araujo, et al. · Cancers · 16

Body composition and endometrial cancer outcomes

2023 · Diana P Arteaga, Corina DeKraker, et al. · JNCI Monographs · 14

Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center

2022 · Diana P. Arteaga, Zaid Saeed-Kamil, et al. · JCO Oncology Practice · 2

Melanoma maligno con mutación BRAF: terapia diana

2017 · Diana Paola Arteaga · Piel · 2

BRAF testing timelines and impact on the starting of systemic treatment.

2021 · Diana Paola Arteaga, Zaid Saeed Kamil, et al. · Journal of Clinical Oncology · 1

Continuing Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Advanced Breast Cancer: A Meta-Analysis

2025 · Neha Pathak, Sudhir Kumar, et al. · Cancers

Data from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Table TS6 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Table TS5 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Figure S4 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Table TS4 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Figure S3 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Table TS2 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Table TS1 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Figure S5 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Figure S1 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Figure S2 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Table TS3 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Figure S2 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Figure S3 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Figure S5 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Figure S1 from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

2023 · Derek Wong, Ping Luo, et al.

Works count: 30

Citation count: 132

H-index: 5

I10-index: 5